DCF Advisers, LLC - Q2 2021 holdings

$282 Million is the total value of DCF Advisers, LLC's 93 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 110.5% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRput$61,427,000143,500
+100.0%
21.76%
MU BuyMICRON TECHNOLOGY INC$14,447,000
+2.4%
170,000
+6.2%
5.12%
-16.6%
REGN BuyREGENERON PHARMACEUTICALS$8,657,000
+35.5%
15,500
+14.8%
3.07%
+10.5%
XNCR BuyXENCOR INC$6,795,000
-16.9%
197,000
+3.7%
2.41%
-32.3%
GDX BuyVANECK VECTORS ETF TRgold miners etf$6,286,000
+51.7%
185,000
+45.1%
2.23%
+23.7%
VZ BuyVERIZON COMMUNICATIONS INC$5,603,000
+10.1%
100,000
+14.3%
1.98%
-10.3%
QQQ BuyINVESCO QQQ TRcall$4,430,000
+38.8%
12,500
+25.0%
1.57%
+13.2%
AMZN NewAMAZON COM INCcall$3,784,0001,100
+100.0%
1.34%
IAU NewISHARES GOLD TRishares new$3,371,000100,000
+100.0%
1.19%
KIN BuyKINDRED BIOSCIENCES INC$3,322,000
+232.5%
362,315
+80.3%
1.18%
+171.2%
GLD NewSPDR GOLD TRput$3,313,00020,000
+100.0%
1.17%
PRTA BuyPROTHENA CORP PLC$3,175,000
+175.6%
61,750
+34.7%
1.12%
+124.6%
BMY BuyBRISTOL-MYERS SQUIBB CO$2,706,000
+7.2%
40,500
+1.2%
0.96%
-12.7%
PFE BuyPFIZER INC$2,545,000
+368.7%
65,000
+333.3%
0.90%
+282.2%
LNSR BuyLENSAR INC$2,423,000
+32.3%
279,788
+10.9%
0.86%
+7.9%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$2,268,000
+42.9%
10,000
+42.9%
0.80%
+16.5%
BMY NewBRISTOL-MYERS SQUIBB COcall$1,671,00025,000
+100.0%
0.59%
SLV BuyISHARES SILVER TRishares$1,453,000
+21.9%
60,000
+14.3%
0.52%
-0.6%
ALT NewALTIMMUNE INC$1,436,000145,750
+100.0%
0.51%
F NewFORD MTR CO DEL$1,337,00090,000
+100.0%
0.47%
PSFE NewPAYSAFE LIMITEDord$1,332,000110,000
+100.0%
0.47%
BABA BuyALIBABA GROUP HLDG LTDcall$1,247,000
+119.9%
5,500
+120.0%
0.44%
+79.7%
AAPL BuyAPPLE INCcall$1,233,000
+101.8%
9,000
+80.0%
0.44%
+64.3%
TSM NewTAIWAN SEMICONDUCTOR MFG LTDput$1,202,00010,000
+100.0%
0.43%
DISCA NewDISCOVERY INC$767,00025,000
+100.0%
0.27%
VIR BuyVIR BIOTECHNOLOGY INC$571,000
+54.7%
12,071
+67.8%
0.20%
+26.2%
OVID BuyOVID THERAPEUTICS INC$546,000
+24.7%
139,701
+28.2%
0.19%
+1.6%
FDX NewFEDEX CORPcall$507,0001,700
+100.0%
0.18%
EQ NewEQUILLIUM INC$457,00077,538
+100.0%
0.16%
VIAC NewVIACOMCBS INCcl b$452,00010,000
+100.0%
0.16%
BIIB NewBIOGEN INC$346,0001,000
+100.0%
0.12%
LIT NewGLOBAL X FDScall$326,0004,500
+100.0%
0.12%
TSM NewTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$300,0002,500
+100.0%
0.11%
MAS NewMASCO CORPcall$295,0005,000
+100.0%
0.10%
KIRK BuyKIRKLANDS INC$252,000
-14.6%
11,000
+4.8%
0.09%
-30.5%
XLE NewSELECT SECTOR SPDR TRput$242,0004,500
+100.0%
0.09%
VIAC NewVIACOMCBS INCcall$226,0005,000
+100.0%
0.08%
AIRT NewAIR T INC$214,0008,673
+100.0%
0.08%
LCTX BuyLINEAGE CELL THERAPEUTICS IN$212,000
+332.7%
74,500
+254.8%
0.08%
+257.1%
SPFRWS NewJAWS SPITFIRE ACQUISITION CO*w exp 12/01/202$58,00030,000
+100.0%
0.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTRA-CELLULAR THERAPIES INC16Q3 202310.2%
MICRON TECHNOLOGY INC16Q3 20236.7%
ALPHABET INC16Q3 20235.8%
ABBVIE INC16Q3 20237.9%
REGENERON PHARMACEUTICALS16Q3 20235.5%
ARGENX SE16Q3 20236.4%
SPDR GOLD TRUST16Q3 20236.6%
XENCOR INC16Q3 20234.1%
BK OF AMERICA CORP16Q3 20235.4%
ORACLE CORP16Q3 20233.2%

View DCF Advisers, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-09
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-13
13F-HR2022-02-10
13F-HR2021-11-15

View DCF Advisers, LLC's complete filings history.

Compare quarters

Export DCF Advisers, LLC's holdings